- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01097213
Neural Mechanisms Underlying Alcohol Induced Disinhibition
March 11, 2013 updated by: Technische Universität Dresden
Collaboration on Alcohol Self Administration in Adolescents and Young Adults - Specific Aim 2: To Examine the Effect of Acute Alcohol Administration on Forebrain Disinhibition Using Functional Magnetic Resonance Imaging (fMRI)
Forty 18-year-old social drinkers will be selected from the sample tested in specific aim 1 ("Prospective Assessment of Adolescent Drinking Trajectories With Computer-Assisted Self-administration of Ethanol (CASE)"; ClinicalTrials.gov
identifier: NCT01063166).
The functional magnetic resonance imaging blood-oxygen-level-dependent (fMRI BOLD) activity related to disinhibition measured with the Stop Signal task will be assessed during a continuous infusion of alcohol, clamping the arterial Breath Alcohol Concentration (aBAC) at 60 mg% for approximately one hour.
It will be examined whether this fMRI BOLD activity is associated with the initial drinking trajectories and the alcohol consumption at age 18 and at age 20 identified in specific aim 1.
Furthermore, fMRI will be used with the Taylor Aggression Paradigm to determine which brain areas mediate increased physical aggression during the same continuous infusion of alcohol as described above.
All participants will undergo an alcohol and a placebo fMRI session.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Actual)
50
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Saxony
-
Dresden, Saxony, Germany, 01187
- Technische Universitaet Dresden - Dresden fMRT-Neuroimaging Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 19 years (ADULT)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
Residents living within 15 km (9.5 miles) from downtown Dresden
Description
Inclusion Criteria:
- male and female Caucasian volunteers aged 18 years/0 months to 19 years/11 months;
- written informed consent by the subject;
- habitual social drinking during the two months preceding participation, defined by at least one drinking day in any two weeks-interval;
- at least one prior experience of alcohol intoxication
- being able to abstain from tobacco use for four hours without developing nicotine withdrawal symptoms;
- effective contraception in female participants;
- consenting to abstain from any illegal substance use for 2 weeks prior to participation;
- living within 15 km (9.5 miles) from downtown Dresden;
- sufficient information concerning alcohol use in both parents and in at least four second-degree relatives
Exclusion Criteria:
- prior medical treatment due to alcohol use;
- current or prior history of any serious disease, including CNS, cardiovascular, respiratory, gastrointestinal, hepatic, renal, endocrine, alcohol or drug dependence, but not alcohol abuse;
- current history of Axis-I psychiatric illness, including premenstrual dysphoric disorder;
- current or prior history of alcohol-induced flushing reactions;
- positive urine screen for cannabinoids, cocaine, amphetamines, opiates, or benzodiazepines;
- light or non-drinkers: averaging less than 2 standard drinks per week in the preceding two months;
- intention to become pregnant
- pregnancy or positive urine pregnancy screening or breast-feeding;
- any alcohol intake on the test day or the day before;
- use of medications known to interact with alcohol within 2 weeks of the study;
- positive hepatitis or HIV at screening, provided the subject consented to these tests
- any conditions posing safety issues with the fMRI scan, such as ferromagnetic implants, cardiac pacemakers or insulin pumps
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Alcohol consumption
Time Frame: 2 years
|
Alcohol consumption, as measured by a Timeline Followback Interview.
|
2 years
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Absolute perfusion levels assessed with arterial spin labeling
Time Frame: 1 week
|
1 week
|
Behavioural Stop Signal Reaction Time (SSRT)
Time Frame: 1 week
|
1 week
|
BOLD fMRI correlate of aggression
Time Frame: 1 week
|
1 week
|
Taylor aggression score
Time Frame: 1 week
|
1 week
|
BOLD fMRI correlate of disinhibition
Time Frame: 1 week
|
1 week
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Michael N. Smolka, Prof. Dr., Technische Universitaet Dresden - - Faculty of Medicine Carl Gustav Carus - Department of Psychiatry and Psychotherapy
- Principal Investigator: Ulrich S. Zimmermann, Dr., Universitaetsklinikum Carl Gustav Carus at the Technische Universitaet Dresden
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
December 1, 2010
Primary Completion (ACTUAL)
April 1, 2012
Study Completion (ACTUAL)
April 1, 2012
Study Registration Dates
First Submitted
March 11, 2010
First Submitted That Met QC Criteria
March 31, 2010
First Posted (ESTIMATE)
April 1, 2010
Study Record Updates
Last Update Posted (ESTIMATE)
March 12, 2013
Last Update Submitted That Met QC Criteria
March 11, 2013
Last Verified
March 1, 2013
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- U01 AA017900 SA2
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Alcoholism
-
Yale UniversityCompletedFamilial Alcoholism VulnerabilityUnited States
-
Yonsei UniversityTerminated
-
Yale UniversityNational Institute on Alcohol Abuse and Alcoholism (NIAAA)RecruitingFamilial Alcoholism VulnerabilityUnited States
-
University of Southern DenmarkActive, not recruitingGeneral Practice | Alcohol Abuse Alcoholism | Screening and Brief InterventionDenmark
-
University of FloridaNational Institute on Alcohol Abuse and Alcoholism (NIAAA)CompletedEffects of Family History of Alcoholism and Sex on Alcohol AnalgesiaUnited States
-
Brown UniversityNational Institute on Alcohol Abuse and Alcoholism (NIAAA)CompletedAlcoholic Liver Disease | Alcoholism,United States
-
Khoo Teck Puat HospitalNot yet recruitingEmergencies | Alcohol Use Disorder | Alcoholism and Alcohol Abuse
-
National Institute on Drug Abuse (NIDA)The Peter G. Dodge Foundation (PGDF)Completed
-
Virginia Commonwealth UniversityNational Institute on Alcohol Abuse and Alcoholism (NIAAA); Yale University; University...CompletedAlcoholismUnited States
-
University of Sao PauloCoordenação de Aperfeiçoamento de Pessoal de Nível Superior.; Conselho Nacional... and other collaboratorsEnrolling by invitation
Clinical Trials on Ethanol
-
Virginia Commonwealth UniversityU.S. Department of JusticeRecruitingElectronic Cigarette UseUnited States
-
Parc de Salut MarCompletedHealthy | Alcohol ConsumptionSpain
-
Yale UniversityVA Connecticut Healthcare SystemCompleted
-
Beth Israel Deaconess Medical CenterNational Institute on Alcohol Abuse and Alcoholism (NIAAA)Completed
-
Virginia Commonwealth UniversityU.S. Department of JusticeCompleted
-
University of NebraskaWithdrawnShort Bowel Syndrome | Blood Stream InfectionsUnited States
-
Merck Sharp & Dohme LLCCompleted
-
National Institute of Diabetes and Digestive and...CompletedType 2 Diabetes, Insulin RequiringUnited States
-
OrfagenFDA Office of Orphan Products DevelopmentCompletedCongenital Venous MalformationUnited States, France
-
Children's Hospital of MichiganBlue Cross Blue Shield of Michigan FoundationCompletedLymphoma | Leukemia | Solid Tumors | Blood DisordersUnited States